Nuvectis Pharma, Inc. (NVCT) Misses Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts NVCT Hot Sheet
Join SI Premium – FREE
Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q2 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Golden Spike Resources plans name change, share consolidation and C$500K raise
- XP Inc. (XP) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
